The global Parkinson’s Disease Therapeutics market was valued at US$ 2337.8 million in 2023 and is anticipated to reach US$ 3533.7 million by 2030, witnessing a CAGR of 6.0% during the forecast period 2024-2030.

Parkinson’s Disease Therapeutics Market

Parkinson's disease therapeutics includes medications and therapies used to manage the symptoms of Parkinson's disease, a neurodegenerative disorder that affects movement and motor control.

The market for Parkinson's disease therapeutics is driven by the increasing prevalence of Parkinson's disease and the demand for symptomatic relief and disease-modifying treatments. The market's growth is also influenced by ongoing research in Parkinson's disease pathophysiology and the development of novel therapeutic approaches.

This report aims to provide a comprehensive presentation of the global market for Parkinson’s Disease Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Parkinson’s Disease Therapeutics.

Report Scope

The Parkinson’s Disease Therapeutics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Parkinson’s Disease Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Parkinson’s Disease Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Parkinson’s Disease Therapeutics Market Report

Report Metric	Details
Report Name	Parkinson’s Disease Therapeutics Market
Accounted market size in 2023	US$ 2337.8 million
Forecasted market size in 2030	US$ 3533.7 million
CAGR	6.0%
Base Year	2023
Forecasted years	2024 - 2030
Segment by Type	Oral Transdermal Subcutaneous Intestinal Infusion
Segment by Application	Hospitals Clinics Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Abbvie, Biogen, Boehringer Ingelheim GmbH, F. Hoffman-La Roche, GlaxoSmithKline, H. Lundbeck A/S, Impax Labs, Newron Pharmaceuticals SpA, Novartis AG, Orion Corporation, Teva Pharmaceutical Industries Ltd., UCB S.A., Livzon Pharmaceutical, Haisco Pharmaceutical, Jingxin Pharmaceutical, Dongcheng Biochemicals
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Parkinson’s Disease Therapeutics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Parkinson’s Disease Therapeutics Market growing?

Ans: The Parkinson’s Disease Therapeutics Market witnessing a CAGR of 6.0% during the forecast period 2024-2030.

What is the Parkinson’s Disease Therapeutics Market size in 2030?

Ans: The Parkinson’s Disease Therapeutics Market size in 2030 will be US$ 3533.7 million.

Who are the main players in the Parkinson’s Disease Therapeutics Market report?

Ans: The main players in the Parkinson’s Disease Therapeutics Market are Abbvie, Biogen, Boehringer Ingelheim GmbH, F. Hoffman-La Roche, GlaxoSmithKline, H. Lundbeck A/S, Impax Labs, Newron Pharmaceuticals SpA, Novartis AG, Orion Corporation, Teva Pharmaceutical Industries Ltd., UCB S.A., Livzon Pharmaceutical, Haisco Pharmaceutical, Jingxin Pharmaceutical, Dongcheng Biochemicals

What are the Application segmentation covered in the Parkinson’s Disease Therapeutics Market report?

Ans: The Applications covered in the Parkinson’s Disease Therapeutics Market report are Hospitals, Clinics, Others

What are the Type segmentation covered in the Parkinson’s Disease Therapeutics Market report?

Ans: The Types covered in the Parkinson’s Disease Therapeutics Market report are Oral, Transdermal, Subcutaneous, Intestinal Infusion

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Parkinson’s Disease Therapeutics Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Oral

1.2.3 Transdermal

1.2.4 Subcutaneous

1.2.5 Intestinal Infusion

1.3 Market by Application

1.3.1 Global Parkinson’s Disease Therapeutics Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Hospitals

1.3.3 Clinics

1.3.4 Others

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global Parkinson’s Disease Therapeutics Market Perspective (2019-2030)

2.2 Parkinson’s Disease Therapeutics Growth Trends by Region

2.2.1 Global Parkinson’s Disease Therapeutics Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Parkinson’s Disease Therapeutics Historic Market Size by Region (2019-2024)

2.2.3 Parkinson’s Disease Therapeutics Forecasted Market Size by Region (2025-2030)

2.3 Parkinson’s Disease Therapeutics Market Dynamics

2.3.1 Parkinson’s Disease Therapeutics Industry Trends

2.3.2 Parkinson’s Disease Therapeutics Market Drivers

2.3.3 Parkinson’s Disease Therapeutics Market Challenges

2.3.4 Parkinson’s Disease Therapeutics Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Parkinson’s Disease Therapeutics Players by Revenue

3.1.1 Global Top Parkinson’s Disease Therapeutics Players by Revenue (2019-2024)

3.1.2 Global Parkinson’s Disease Therapeutics Revenue Market Share by Players (2019-2024)

3.2 Global Parkinson’s Disease Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Parkinson’s Disease Therapeutics Revenue

3.4 Global Parkinson’s Disease Therapeutics Market Concentration Ratio

3.4.1 Global Parkinson’s Disease Therapeutics Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Parkinson’s Disease Therapeutics Revenue in 2023

3.5 Parkinson’s Disease Therapeutics Key Players Head office and Area Served

3.6 Key Players Parkinson’s Disease Therapeutics Product Solution and Service

3.7 Date of Enter into Parkinson’s Disease Therapeutics Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Parkinson’s Disease Therapeutics Breakdown Data by Type

4.1 Global Parkinson’s Disease Therapeutics Historic Market Size by Type (2019-2024)

4.2 Global Parkinson’s Disease Therapeutics Forecasted Market Size by Type (2025-2030)

5 Parkinson’s Disease Therapeutics Breakdown Data by Application

5.1 Global Parkinson’s Disease Therapeutics Historic Market Size by Application (2019-2024)

5.2 Global Parkinson’s Disease Therapeutics Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Parkinson’s Disease Therapeutics Market Size (2019-2030)

6.2 North America Parkinson’s Disease Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Parkinson’s Disease Therapeutics Market Size by Country (2019-2024)

6.4 North America Parkinson’s Disease Therapeutics Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Parkinson’s Disease Therapeutics Market Size (2019-2030)

7.2 Europe Parkinson’s Disease Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Parkinson’s Disease Therapeutics Market Size by Country (2019-2024)

7.4 Europe Parkinson’s Disease Therapeutics Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Parkinson’s Disease Therapeutics Market Size (2019-2030)

8.2 Asia-Pacific Parkinson’s Disease Therapeutics Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Parkinson’s Disease Therapeutics Market Size by Region (2019-2024)

8.4 Asia-Pacific Parkinson’s Disease Therapeutics Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Parkinson’s Disease Therapeutics Market Size (2019-2030)

9.2 Latin America Parkinson’s Disease Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Parkinson’s Disease Therapeutics Market Size by Country (2019-2024)

9.4 Latin America Parkinson’s Disease Therapeutics Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Parkinson’s Disease Therapeutics Market Size (2019-2030)

10.2 Middle East & Africa Parkinson’s Disease Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Parkinson’s Disease Therapeutics Market Size by Country (2019-2024)

10.4 Middle East & Africa Parkinson’s Disease Therapeutics Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Abbvie

11.1.1 Abbvie Company Detail

11.1.2 Abbvie Business Overview

11.1.3 Abbvie Parkinson’s Disease Therapeutics Introduction

11.1.4 Abbvie Revenue in Parkinson’s Disease Therapeutics Business (2019-2024)

11.1.5 Abbvie Recent Development

11.2 Biogen

11.2.1 Biogen Company Detail

11.2.2 Biogen Business Overview

11.2.3 Biogen Parkinson’s Disease Therapeutics Introduction

11.2.4 Biogen Revenue in Parkinson’s Disease Therapeutics Business (2019-2024)

11.2.5 Biogen Recent Development

11.3 Boehringer Ingelheim GmbH

11.3.1 Boehringer Ingelheim GmbH Company Detail

11.3.2 Boehringer Ingelheim GmbH Business Overview

11.3.3 Boehringer Ingelheim GmbH Parkinson’s Disease Therapeutics Introduction

11.3.4 Boehringer Ingelheim GmbH Revenue in Parkinson’s Disease Therapeutics Business (2019-2024)

11.3.5 Boehringer Ingelheim GmbH Recent Development

11.4 F. Hoffman-La Roche

11.4.1 F. Hoffman-La Roche Company Detail

11.4.2 F. Hoffman-La Roche Business Overview

11.4.3 F. Hoffman-La Roche Parkinson’s Disease Therapeutics Introduction

11.4.4 F. Hoffman-La Roche Revenue in Parkinson’s Disease Therapeutics Business (2019-2024)

11.4.5 F. Hoffman-La Roche Recent Development

11.5 GlaxoSmithKline

11.5.1 GlaxoSmithKline Company Detail

11.5.2 GlaxoSmithKline Business Overview

11.5.3 GlaxoSmithKline Parkinson’s Disease Therapeutics Introduction

11.5.4 GlaxoSmithKline Revenue in Parkinson’s Disease Therapeutics Business (2019-2024)

11.5.5 GlaxoSmithKline Recent Development

11.6 H. Lundbeck A/S

11.6.1 H. Lundbeck A/S Company Detail

11.6.2 H. Lundbeck A/S Business Overview

11.6.3 H. Lundbeck A/S Parkinson’s Disease Therapeutics Introduction

11.6.4 H. Lundbeck A/S Revenue in Parkinson’s Disease Therapeutics Business (2019-2024)

11.6.5 H. Lundbeck A/S Recent Development

11.7 Impax Labs

11.7.1 Impax Labs Company Detail

11.7.2 Impax Labs Business Overview

11.7.3 Impax Labs Parkinson’s Disease Therapeutics Introduction

11.7.4 Impax Labs Revenue in Parkinson’s Disease Therapeutics Business (2019-2024)

11.7.5 Impax Labs Recent Development

11.8 Newron Pharmaceuticals SpA

11.8.1 Newron Pharmaceuticals SpA Company Detail

11.8.2 Newron Pharmaceuticals SpA Business Overview

11.8.3 Newron Pharmaceuticals SpA Parkinson’s Disease Therapeutics Introduction

11.8.4 Newron Pharmaceuticals SpA Revenue in Parkinson’s Disease Therapeutics Business (2019-2024)

11.8.5 Newron Pharmaceuticals SpA Recent Development

11.9 Novartis AG

11.9.1 Novartis AG Company Detail

11.9.2 Novartis AG Business Overview

11.9.3 Novartis AG Parkinson’s Disease Therapeutics Introduction

11.9.4 Novartis AG Revenue in Parkinson’s Disease Therapeutics Business (2019-2024)

11.9.5 Novartis AG Recent Development

11.10 Orion Corporation

11.10.1 Orion Corporation Company Detail

11.10.2 Orion Corporation Business Overview

11.10.3 Orion Corporation Parkinson’s Disease Therapeutics Introduction

11.10.4 Orion Corporation Revenue in Parkinson’s Disease Therapeutics Business (2019-2024)

11.10.5 Orion Corporation Recent Development

11.11 Teva Pharmaceutical Industries Ltd.

11.11.1 Teva Pharmaceutical Industries Ltd. Company Detail

11.11.2 Teva Pharmaceutical Industries Ltd. Business Overview

11.11.3 Teva Pharmaceutical Industries Ltd. Parkinson’s Disease Therapeutics Introduction

11.11.4 Teva Pharmaceutical Industries Ltd. Revenue in Parkinson’s Disease Therapeutics Business (2019-2024)

11.11.5 Teva Pharmaceutical Industries Ltd. Recent Development

11.12 UCB S.A.

11.12.1 UCB S.A. Company Detail

11.12.2 UCB S.A. Business Overview

11.12.3 UCB S.A. Parkinson’s Disease Therapeutics Introduction

11.12.4 UCB S.A. Revenue in Parkinson’s Disease Therapeutics Business (2019-2024)

11.12.5 UCB S.A. Recent Development

11.13 Livzon Pharmaceutical

11.13.1 Livzon Pharmaceutical Company Detail

11.13.2 Livzon Pharmaceutical Business Overview

11.13.3 Livzon Pharmaceutical Parkinson’s Disease Therapeutics Introduction

11.13.4 Livzon Pharmaceutical Revenue in Parkinson’s Disease Therapeutics Business (2019-2024)

11.13.5 Livzon Pharmaceutical Recent Development

11.14 Haisco Pharmaceutical

11.14.1 Haisco Pharmaceutical Company Detail

11.14.2 Haisco Pharmaceutical Business Overview

11.14.3 Haisco Pharmaceutical Parkinson’s Disease Therapeutics Introduction

11.14.4 Haisco Pharmaceutical Revenue in Parkinson’s Disease Therapeutics Business (2019-2024)

11.14.5 Haisco Pharmaceutical Recent Development

11.15 Jingxin Pharmaceutical

11.15.1 Jingxin Pharmaceutical Company Detail

11.15.2 Jingxin Pharmaceutical Business Overview

11.15.3 Jingxin Pharmaceutical Parkinson’s Disease Therapeutics Introduction

11.15.4 Jingxin Pharmaceutical Revenue in Parkinson’s Disease Therapeutics Business (2019-2024)

11.15.5 Jingxin Pharmaceutical Recent Development

11.16 Dongcheng Biochemicals

11.16.1 Dongcheng Biochemicals Company Detail

11.16.2 Dongcheng Biochemicals Business Overview

11.16.3 Dongcheng Biochemicals Parkinson’s Disease Therapeutics Introduction

11.16.4 Dongcheng Biochemicals Revenue in Parkinson’s Disease Therapeutics Business (2019-2024)

11.16.5 Dongcheng Biochemicals Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

AbbVie

Novartis

Biogen

Boehringer Ingelheim GmbH

Newron Pharmaceuticals SpA

Orion Corporation

Teva Pharmaceutical Industries Ltd

UCB

Livzon Pharmaceutical

Haisco Pharmaceutical

JINGXIN PHARMACEUTICAL

Dongcheng Biochemicals

List of Tables

Table 1. Global Parkinson’s Disease Therapeutics Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Oral

Table 3. Key Players of Transdermal

Table 4. Key Players of Subcutaneous

Table 5. Key Players of Intestinal Infusion

Table 6. Global Parkinson’s Disease Therapeutics Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 7. Global Parkinson’s Disease Therapeutics Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 8. Global Parkinson’s Disease Therapeutics Market Size by Region (2019-2024) & (US$ Million)

Table 9. Global Parkinson’s Disease Therapeutics Market Share by Region (2019-2024)

Table 10. Global Parkinson’s Disease Therapeutics Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 11. Global Parkinson’s Disease Therapeutics Market Share by Region (2025-2030)

Table 12. Parkinson’s Disease Therapeutics Market Trends

Table 13. Parkinson’s Disease Therapeutics Market Drivers

Table 14. Parkinson’s Disease Therapeutics Market Challenges

Table 15. Parkinson’s Disease Therapeutics Market Restraints

Table 16. Global Parkinson’s Disease Therapeutics Revenue by Players (2019-2024) & (US$ Million)

Table 17. Global Parkinson’s Disease Therapeutics Market Share by Players (2019-2024)

Table 18. Global Top Parkinson’s Disease Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Parkinson’s Disease Therapeutics as of 2023)

Table 19. Ranking of Global Top Parkinson’s Disease Therapeutics Companies by Revenue (US$ Million) in 2023

Table 20. Global 5 Largest Players Market Share by Parkinson’s Disease Therapeutics Revenue (CR5 and HHI) & (2019-2024)

Table 21. Key Players Headquarters and Area Served

Table 22. Key Players Parkinson’s Disease Therapeutics Product Solution and Service

Table 23. Date of Enter into Parkinson’s Disease Therapeutics Market

Table 24. Mergers & Acquisitions, Expansion Plans

Table 25. Global Parkinson’s Disease Therapeutics Market Size by Type (2019-2024) & (US$ Million)

Table 26. Global Parkinson’s Disease Therapeutics Revenue Market Share by Type (2019-2024)

Table 27. Global Parkinson’s Disease Therapeutics Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 28. Global Parkinson’s Disease Therapeutics Revenue Market Share by Type (2025-2030)

Table 29. Global Parkinson’s Disease Therapeutics Market Size by Application (2019-2024) & (US$ Million)

Table 30. Global Parkinson’s Disease Therapeutics Revenue Market Share by Application (2019-2024)

Table 31. Global Parkinson’s Disease Therapeutics Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 32. Global Parkinson’s Disease Therapeutics Revenue Market Share by Application (2025-2030)

Table 33. North America Parkinson’s Disease Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 34. North America Parkinson’s Disease Therapeutics Market Size by Country (2019-2024) & (US$ Million)

Table 35. North America Parkinson’s Disease Therapeutics Market Size by Country (2025-2030) & (US$ Million)

Table 36. Europe Parkinson’s Disease Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 37. Europe Parkinson’s Disease Therapeutics Market Size by Country (2019-2024) & (US$ Million)

Table 38. Europe Parkinson’s Disease Therapeutics Market Size by Country (2025-2030) & (US$ Million)

Table 39. Asia-Pacific Parkinson’s Disease Therapeutics Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 40. Asia-Pacific Parkinson’s Disease Therapeutics Market Size by Region (2019-2024) & (US$ Million)

Table 41. Asia-Pacific Parkinson’s Disease Therapeutics Market Size by Region (2025-2030) & (US$ Million)

Table 42. Latin America Parkinson’s Disease Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 43. Latin America Parkinson’s Disease Therapeutics Market Size by Country (2019-2024) & (US$ Million)

Table 44. Latin America Parkinson’s Disease Therapeutics Market Size by Country (2025-2030) & (US$ Million)

Table 45. Middle East & Africa Parkinson’s Disease Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 46. Middle East & Africa Parkinson’s Disease Therapeutics Market Size by Country (2019-2024) & (US$ Million)

Table 47. Middle East & Africa Parkinson’s Disease Therapeutics Market Size by Country (2025-2030) & (US$ Million)

Table 48. Abbvie Company Detail

Table 49. Abbvie Business Overview

Table 50. Abbvie Parkinson’s Disease Therapeutics Product

Table 51. Abbvie Revenue in Parkinson’s Disease Therapeutics Business (2019-2024) & (US$ Million)

Table 52. Abbvie Recent Development

Table 53. Biogen Company Detail

Table 54. Biogen Business Overview

Table 55. Biogen Parkinson’s Disease Therapeutics Product

Table 56. Biogen Revenue in Parkinson’s Disease Therapeutics Business (2019-2024) & (US$ Million)

Table 57. Biogen Recent Development

Table 58. Boehringer Ingelheim GmbH Company Detail

Table 59. Boehringer Ingelheim GmbH Business Overview

Table 60. Boehringer Ingelheim GmbH Parkinson’s Disease Therapeutics Product

Table 61. Boehringer Ingelheim GmbH Revenue in Parkinson’s Disease Therapeutics Business (2019-2024) & (US$ Million)

Table 62. Boehringer Ingelheim GmbH Recent Development

Table 63. F. Hoffman-La Roche Company Detail

Table 64. F. Hoffman-La Roche Business Overview

Table 65. F. Hoffman-La Roche Parkinson’s Disease Therapeutics Product

Table 66. F. Hoffman-La Roche Revenue in Parkinson’s Disease Therapeutics Business (2019-2024) & (US$ Million)

Table 67. F. Hoffman-La Roche Recent Development

Table 68. GlaxoSmithKline Company Detail

Table 69. GlaxoSmithKline Business Overview

Table 70. GlaxoSmithKline Parkinson’s Disease Therapeutics Product

Table 71. GlaxoSmithKline Revenue in Parkinson’s Disease Therapeutics Business (2019-2024) & (US$ Million)

Table 72. GlaxoSmithKline Recent Development

Table 73. H. Lundbeck A/S Company Detail

Table 74. H. Lundbeck A/S Business Overview

Table 75. H. Lundbeck A/S Parkinson’s Disease Therapeutics Product

Table 76. H. Lundbeck A/S Revenue in Parkinson’s Disease Therapeutics Business (2019-2024) & (US$ Million)

Table 77. H. Lundbeck A/S Recent Development

Table 78. Impax Labs Company Detail

Table 79. Impax Labs Business Overview

Table 80. Impax Labs Parkinson’s Disease Therapeutics Product

Table 81. Impax Labs Revenue in Parkinson’s Disease Therapeutics Business (2019-2024) & (US$ Million)

Table 82. Impax Labs Recent Development

Table 83. Newron Pharmaceuticals SpA Company Detail

Table 84. Newron Pharmaceuticals SpA Business Overview

Table 85. Newron Pharmaceuticals SpA Parkinson’s Disease Therapeutics Product

Table 86. Newron Pharmaceuticals SpA Revenue in Parkinson’s Disease Therapeutics Business (2019-2024) & (US$ Million)

Table 87. Newron Pharmaceuticals SpA Recent Development

Table 88. Novartis AG Company Detail

Table 89. Novartis AG Business Overview

Table 90. Novartis AG Parkinson’s Disease Therapeutics Product

Table 91. Novartis AG Revenue in Parkinson’s Disease Therapeutics Business (2019-2024) & (US$ Million)

Table 92. Novartis AG Recent Development

Table 93. Orion Corporation Company Detail

Table 94. Orion Corporation Business Overview

Table 95. Orion Corporation Parkinson’s Disease Therapeutics Product

Table 96. Orion Corporation Revenue in Parkinson’s Disease Therapeutics Business (2019-2024) & (US$ Million)

Table 97. Orion Corporation Recent Development

Table 98. Teva Pharmaceutical Industries Ltd. Company Detail

Table 99. Teva Pharmaceutical Industries Ltd. Business Overview

Table 100. Teva Pharmaceutical Industries Ltd. Parkinson’s Disease Therapeutics Product

Table 101. Teva Pharmaceutical Industries Ltd. Revenue in Parkinson’s Disease Therapeutics Business (2019-2024) & (US$ Million)

Table 102. Teva Pharmaceutical Industries Ltd. Recent Development

Table 103. UCB S.A. Company Detail

Table 104. UCB S.A. Business Overview

Table 105. UCB S.A. Parkinson’s Disease Therapeutics Product

Table 106. UCB S.A. Revenue in Parkinson’s Disease Therapeutics Business (2019-2024) & (US$ Million)

Table 107. UCB S.A. Recent Development

Table 108. Livzon Pharmaceutical Company Detail

Table 109. Livzon Pharmaceutical Business Overview

Table 110. Livzon Pharmaceutical Parkinson’s Disease Therapeutics Product

Table 111. Livzon Pharmaceutical Revenue in Parkinson’s Disease Therapeutics Business (2019-2024) & (US$ Million)

Table 112. Livzon Pharmaceutical Recent Development

Table 113. Haisco Pharmaceutical Company Detail

Table 114. Haisco Pharmaceutical Business Overview

Table 115. Haisco Pharmaceutical Parkinson’s Disease Therapeutics Product

Table 116. Haisco Pharmaceutical Revenue in Parkinson’s Disease Therapeutics Business (2019-2024) & (US$ Million)

Table 117. Haisco Pharmaceutical Recent Development

Table 118. Jingxin Pharmaceutical Company Detail

Table 119. Jingxin Pharmaceutical Business Overview

Table 120. Jingxin Pharmaceutical Parkinson’s Disease Therapeutics Product

Table 121. Jingxin Pharmaceutical Revenue in Parkinson’s Disease Therapeutics Business (2019-2024) & (US$ Million)

Table 122. Jingxin Pharmaceutical Recent Development

Table 123. Dongcheng Biochemicals Company Detail

Table 124. Dongcheng Biochemicals Business Overview

Table 125. Dongcheng Biochemicals Parkinson’s Disease Therapeutics Product

Table 126. Dongcheng Biochemicals Revenue in Parkinson’s Disease Therapeutics Business (2019-2024) & (US$ Million)

Table 127. Dongcheng Biochemicals Recent Development

Table 128. Research Programs/Design for This Report

Table 129. Key Data Information from Secondary Sources

Table 130. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Parkinson’s Disease Therapeutics Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global Parkinson’s Disease Therapeutics Market Share by Type: 2023 VS 2030

Figure 3. Oral Features

Figure 4. Transdermal Features

Figure 5. Subcutaneous Features

Figure 6. Intestinal Infusion Features

Figure 7. Global Parkinson’s Disease Therapeutics Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 8. Global Parkinson’s Disease Therapeutics Market Share by Application: 2023 VS 2030

Figure 9. Hospitals Case Studies

Figure 10. Clinics Case Studies

Figure 11. Others Case Studies

Figure 12. Parkinson’s Disease Therapeutics Report Years Considered

Figure 13. Global Parkinson’s Disease Therapeutics Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 14. Global Parkinson’s Disease Therapeutics Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 15. Global Parkinson’s Disease Therapeutics Market Share by Region: 2023 VS 2030

Figure 16. Global Parkinson’s Disease Therapeutics Market Share by Players in 2023

Figure 17. Global Top Parkinson’s Disease Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Parkinson’s Disease Therapeutics as of 2023)

Figure 18. The Top 10 and 5 Players Market Share by Parkinson’s Disease Therapeutics Revenue in 2023

Figure 19. North America Parkinson’s Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 20. North America Parkinson’s Disease Therapeutics Market Share by Country (2019-2030)

Figure 21. United States Parkinson’s Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 22. Canada Parkinson’s Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. Europe Parkinson’s Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. Europe Parkinson’s Disease Therapeutics Market Share by Country (2019-2030)

Figure 25. Germany Parkinson’s Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. France Parkinson’s Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. U.K. Parkinson’s Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. Italy Parkinson’s Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Russia Parkinson’s Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Nordic Countries Parkinson’s Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Asia-Pacific Parkinson’s Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Asia-Pacific Parkinson’s Disease Therapeutics Market Share by Region (2019-2030)

Figure 33. China Parkinson’s Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. Japan Parkinson’s Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. South Korea Parkinson’s Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. Southeast Asia Parkinson’s Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. India Parkinson’s Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. Australia Parkinson’s Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. Latin America Parkinson’s Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. Latin America Parkinson’s Disease Therapeutics Market Share by Country (2019-2030)

Figure 41. Mexico Parkinson’s Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. Brazil Parkinson’s Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Middle East & Africa Parkinson’s Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Middle East & Africa Parkinson’s Disease Therapeutics Market Share by Country (2019-2030)

Figure 45. Turkey Parkinson’s Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Saudi Arabia Parkinson’s Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. Abbvie Revenue Growth Rate in Parkinson’s Disease Therapeutics Business (2019-2024)

Figure 48. Biogen Revenue Growth Rate in Parkinson’s Disease Therapeutics Business (2019-2024)

Figure 49. Boehringer Ingelheim GmbH Revenue Growth Rate in Parkinson’s Disease Therapeutics Business (2019-2024)

Figure 50. F. Hoffman-La Roche Revenue Growth Rate in Parkinson’s Disease Therapeutics Business (2019-2024)

Figure 51. GlaxoSmithKline Revenue Growth Rate in Parkinson’s Disease Therapeutics Business (2019-2024)

Figure 52. H. Lundbeck A/S Revenue Growth Rate in Parkinson’s Disease Therapeutics Business (2019-2024)

Figure 53. Impax Labs Revenue Growth Rate in Parkinson’s Disease Therapeutics Business (2019-2024)

Figure 54. Newron Pharmaceuticals SpA Revenue Growth Rate in Parkinson’s Disease Therapeutics Business (2019-2024)

Figure 55. Novartis AG Revenue Growth Rate in Parkinson’s Disease Therapeutics Business (2019-2024)

Figure 56. Orion Corporation Revenue Growth Rate in Parkinson’s Disease Therapeutics Business (2019-2024)

Figure 57. Teva Pharmaceutical Industries Ltd. Revenue Growth Rate in Parkinson’s Disease Therapeutics Business (2019-2024)

Figure 58. UCB S.A. Revenue Growth Rate in Parkinson’s Disease Therapeutics Business (2019-2024)

Figure 59. Livzon Pharmaceutical Revenue Growth Rate in Parkinson’s Disease Therapeutics Business (2019-2024)

Figure 60. Haisco Pharmaceutical Revenue Growth Rate in Parkinson’s Disease Therapeutics Business (2019-2024)

Figure 61. Jingxin Pharmaceutical Revenue Growth Rate in Parkinson’s Disease Therapeutics Business (2019-2024)

Figure 62. Dongcheng Biochemicals Revenue Growth Rate in Parkinson’s Disease Therapeutics Business (2019-2024)

Figure 63. Bottom-up and Top-down Approaches for This Report

Figure 64. Data Triangulation

Figure 65. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions